Boston, MA · Founded 2022 · Privately Held (backing)
Developer of gene expression analysis technology designed to study optically extract multi-omic information from biological tissue. Stellaromics is based in Boston, MA and was founded in 2022. Its last reported valuation was $163 million in Dec 2024. It has raised $105 million.
Last reported valuation
$163.0M
Oct 2026
Priced at
—
Total raised
$105.0M
Last round
—
Cap table — not yet on record
Stellaromics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Stellaromics with a free account
·Watch Stellaromics: the Monday email on marks, rounds and moves
